Skip to main content
. 2019 Feb 28;120(7):728–745. doi: 10.1038/s41416-019-0405-x

Fig. 4.

Fig. 4

Clinical outcome of SHON protein cytoplasmic expression in ERα breast cancer patients. Kaplan–Meier plots of the rates of breast cancer specific survival (BCSS; months) in the NUH-ERαESBC cohort (= 697) according to SHON protein cytoplasmic expression (SHON-Cyto) status. The p value from the log rank test is shown in each panel; ‘n' is the number of samples in each group. High risk, NPI scores ≥ 3.4; ERα, oestrogen receptor α; +, positive expression; −, negative expression